chlorine has been researched along with Hand-Foot Syndrome in 1 studies
chloride : A halide anion formed when chlorine picks up an electron to form an an anion.
Hand-Foot Syndrome: Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Templeton, AJ | 1 |
| Ribi, K | 1 |
| Surber, C | 1 |
| Sun, H | 1 |
| Hsu Schmitz, SF | 1 |
| Beyeler, M | 1 |
| Dietrich, D | 1 |
| Borner, M | 1 |
| Winkler, A | 1 |
| Müller, A | 1 |
| von Rohr, L | 1 |
| Winterhalder, RC | 1 |
| Rochlitz, C | 1 |
| von Moos, R | 1 |
| Zaman, K | 1 |
| Thürlimann, BJ | 1 |
| Ruhstaller, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Local Antiperspirant for Prevention of Palmar-Plantar Erythrodysesthesia (PPE) in Patients Treated With Pegylated Liposomal Doxorubicin: A Randomized, Multicenter, Double Blinded, Phase III Trial[NCT00992706] | Phase 3 | 91 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for chlorine and Hand-Foot Syndrome
| Article | Year |
|---|---|
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Topics: Administration, Topical; Aged; Aluminum Hydroxide; Antiperspirants; Breast Neoplasms; Chlorides; Dou | 2014 |